Has research investigated chronic viral or bacterial infections in patients with endometriosis who present with chronic‑fatigue/fibromyalgia‑type symptoms and elevated systemic inflammatory index (SII), erythrocyte sedimentation rate (ESR), and C‑reactive protein (CRP)?

Endometriosis and Chronic Viral Infections with CFS/Fibromyalgia Symptoms

Yes, research has documented significant associations between endometriosis and chronic fatigue syndrome/fibromyalgia, with emerging evidence linking these conditions to chronic viral infections and systemic inflammation—your patient's presentation with elevated inflammatory markers (SII, ESR, CRP) and intermittent systemic symptoms fits a recognized clinical phenotype.

The Evidence Base

The most relevant guideline evidence comes from the 2023 Nature Reviews Microbiology Long COVID review 11, which explicitly identifies endometriosis as commonly comorbid with ME/CFS and notes that these conditions share overlapping pathophysiology with post-viral syndromes. The review documents that ME/CFS is associated with:

• Viral persistence as a triggering mechanism
• Dysautonomia (particularly POTS)
• Mast cell activation syndrome
• Endometriosis as a specific comorbidity
• Menstrual cycle fluctuations that affect symptom severity

Critically, the guideline notes that "pregnancy, postpartum changes, perimenopause and menstrual cycle fluctuations affect ME/CFS and influence metabolic and immune system changes" 1—which directly explains your patient's wave-like symptom pattern.

Direct Research Confirmation

A 2021 population-based case-control study 2 found that chronic fatigue syndrome and/or fibromyalgia had a 5.81-fold increased odds of co-occurring with endometriosis (95% CI: 1.89-17.9). The same study documented increased odds for:

• Previous mononucleosis infection (OR: 1.75)—a chronic viral trigger
• Autoimmune/inflammatory conditions (OR: 1.87)
• A positive dose-response relationship: more immune-mediated conditions correlated with higher endometriosis risk (p-trend=0.0002)

A 2024 study 3 demonstrated that fibromyalgia patients have significantly elevated rates of viral infections including:

• Influenza (OR: 1.80)
• Symptomatic COVID-19 (OR: 1.76)
• Cytomegalovirus (OR: 1.85)
• Multiple bacterial and fungal infections

Your Patient's Inflammatory Profile

Your patient's elevated SII, ESR, and CRP are well-documented in endometriosis research:

• SII (Systemic Immune-Inflammation Index) is significantly elevated in endometriosis patients 45, with a 2025 study showing 76% sensitivity and 70% specificity using a cut-off of 538
• ESR and CRP are both elevated in endometriosis 6, though they show 27.3% discordance (one elevated while the other is normal), meaning both should be measured
• A 2026 study 7 confirmed that SII, SIRI, and PIV are all significantly associated with endometriosis-related pathology

The intermittent, wave-like pattern of symptoms (body aches, chills, muscle pains, skin pains, hot flashes) aligns with:

1. Menstrual cycle-triggered inflammatory flares documented in ME/CFS-endometriosis overlap 1
2. Mast cell activation syndrome patterns common in both conditions 1

Clinical Approach for Your Patient

Investigate for:

1. Chronic viral reactivation

   • EBV serology (VCA-IgG, EBNA, early antigen)
   • CMV IgG/IgM
   • HHV-6 testing if available
   • Consider COVID-19 antibody testing and long COVID assessment

2. Dysautonomia screening

   • Orthostatic vital signs (POTS occurs in 67% of long COVID patients 1)
   • Consider tilt-table testing if positive

3. Mast cell activation

   • Trial of H1/H2 histamine receptor antagonists (showed improvement in majority of long COVID patients 1)
   • Serum tryptase if available

4. Gut dysbiosis

   • Consider microbiome testing—endometriosis patients show specific dysbiosis patterns 8 with correlations to inflammatory markers

Management priorities:

• Hormonal modulation of endometriosis may reduce inflammatory flares
• Antihistamine trial (H1 + H2 blockers) for mast cell component
• Pacing strategies for ME/CFS symptoms (avoid post-exertional malaise)
• Screen for and treat any active viral infections
• Monitor inflammatory markers to track disease activity

Critical Pitfalls

• Don't dismiss the viral connection: Previous mononucleosis and other viral infections are documented risk factors 2
• Don't ignore the menstrual timing: The week before menstruation triggers symptom relapses in post-viral conditions 1
• Don't rely on single inflammatory markers: CRP and ESR show 27% discordance 6; SII adds independent diagnostic value 4
• Don't overlook gut involvement: Dysbiosis correlates with both endometriosis inflammation 8 and ME/CFS pathophysiology 1

The literature strongly supports that your patient represents a recognized phenotype at the intersection of endometriosis, chronic viral infection sequelae, and ME/CFS/fibromyalgia, with systemic inflammation as a unifying mechanism.